Patents by Inventor Samuel N. Okpanyi

Samuel N. Okpanyi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5618537
    Abstract: Plant-based medicament having tonicising action on smooth muscular organs which are atonic or have decreased tone. The medicament contains Iberis amara, preferably Iberis amara totalis (flowers, seeds, leaves, stalk and roots), in particular as a plant extract or its constituents, optionally together with one or more other constituents selected from the group consisting of Menthae piperitae, Matricariae, Carvi fructus, Melissae folium and Liquiritiae radix, as the sole carrier(s) of the activity. Methods of treating patients comprising administering the medicaments.
    Type: Grant
    Filed: January 30, 1995
    Date of Patent: April 8, 1997
    Assignee: Steigerwald Arzneimittelwerk GmbH
    Inventor: Samuel N. Okpanyi
  • Patent number: 5401777
    Abstract: The invention relates to the use of preparations of the plant Curcuma longa or other curcumin-containing plants, curcumin or curcumin derivatives for the prophylaxis and/or treatment of conditions associated with excessive formation of leucotrienes and/or prostaglandins and to the use of preparations of the plant Curcuma longa or other curcumin-containing plants, curcumin or curcumin derivatives for the production of medicaments for the prophylaxis and/or treatment of conditions associated with excessive formation of leucotrienes and/or prostaglandins.
    Type: Grant
    Filed: November 10, 1992
    Date of Patent: March 28, 1995
    Assignee: Steigerwald Arzneimittelwerk GmbH
    Inventors: H. P. T. Ammon, Hasan Safayhi, Samuel N. Okpanyi
  • Patent number: 5376372
    Abstract: The use of the medicament having analgesic and inflammation-inhibiting action on a plant basis and containing the constituentsPopulus tremulaSolidago virgaureaFraxinus excelsioras the sole carrier of the activity as a basic therapeutic is described.
    Type: Grant
    Filed: March 1, 1993
    Date of Patent: December 27, 1994
    Assignee: Steigerwald Arzneimittelwerk GmbH
    Inventors: Samuel N. Okpanyi, Michaela Arens-Corell